U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Health King Enterprises & Balanceuticals Group, Inc. - 06/24/2014
  1. Warning Letters


Health King Enterprises & Balanceuticals Group, Inc.

Health King Enterprises & Balanceuticals Group, Inc.

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Food and Drug Administration
 Chicago District
550 West Jackson Blvd., 15th Floor
Chicago, Illinois 60661
Telephone: 312-353-5863


June 24, 2014

Mr. Xingwu Liu
Health King Enterprises & Balanceuticals Group, Inc.
238 West 31st Street
Chicago, Illinois 60616

Dear Mr. Liu:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, CHI-14-13 dated July 11, 2013. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.




Scott J. MacIntire
District Director


cc: Mr. James Liu, General Manager

Back to Top